Form 4: Clene Inc. Director David J. Matlin Acquires Shares and Warrants
SEC Form 4
Director David J. Matlin reports acquisition of Clene Inc. shares and warrants, increasing his direct and indirect holdings.
Summary
- On September 30, 2024, David J. Matlin, a director of Clene Inc., acquired 92,307 shares of common stock at a price of $4.75 per share.
- The transaction also involved the acquisition of warrants to purchase 92,307 shares of common stock at an exercise price of $4.82.
- Following the reported transactions, Matlin directly owns 444,491 shares of common stock and indirectly owns 7,500 shares through the Matlin Family Trust 2020.
- The warrants expire on October 1, 2029.
- A 1-for-20 reverse stock split occurred on July 11, 2024, which reduced Matlin's previously held shares.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of insider trading activity. The director's purchase could be seen as a positive signal, but it's not definitively bullish.
Positives
- Director's purchase of shares and warrants may signal confidence in the company's future prospects.
Industry Context
Form 4 filings are standard disclosures for corporate insiders and provide transparency into their transactions in the company's stock.
Stakeholder Impact
- Shareholders may view the director's purchase as a positive sign.
Key Dates
| Date | Description |
|---|---|
| July 11, 2024 | 1-for-20 reverse stock split |
| September 30, 2024 | Acquisition of shares and warrants by David J. Matlin |
| October 01, 2029 | Expiration date of warrants |
| October 02, 2024 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.